Therapeutic Potential of microRNA Against Th2-associated Immune Disorders

Author(s): Sunil Kumar, Muhammad Umer Ashraf, Anil Kumar, Yong-Soo Bae*

Journal Name: Current Topics in Medicinal Chemistry

Volume 21 , Issue 8 , 2021

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


MicroRNAs (miRNAs) are short ~18-22 nucleotide, single-stranded, non-coding RNA molecules playing a crucial role in regulating diverse biological processes and are frequently dysregulated during disease pathogenesis. Thus, targeting miRNA could be a potential candidate for therapeutic invention. This systemic review aims to summarize our current understanding regarding the role of miRNAs associated with Th2-mediated immune disorders and strategies for therapeutic drug development and current clinical trials.

Keywords: microRNA therapeutics, Th2-disorder, Dendritic cells, Asthma, Atopic dermatitis, Rhinitis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 03 March, 2021
Page: [753 - 766]
Pages: 14
DOI: 10.2174/1568026621666210303150235
Price: $65

Article Metrics

PDF: 44